LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

Search

Alkermes PLC

Fechado

SetorSaúde

29.09 2.86

Visão Geral

Variação de preço das ações

24h

Atual

Mín

28.82

Máximo

29.12

Indicadores-chave

By Trading Economics

Rendimento

65M

87M

Vendas

84M

391M

P/E

Médio do Setor

12.821

34.427

EPS

0.291

Margem de lucro

22.295

Funcionários

1,800

EBITDA

79M

93M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+33.05% upside

Dividendos

By Dow Jones

Próximos Ganhos

23 de out. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

69M

4.4B

Abertura anterior

26.23

Fecho anterior

29.09

Sentimento de Notícias

By Acuity

50%

50%

157 / 374 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

Alkermes PLC Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

15 de ago. de 2025, 16:11 UTC

Grandes Movimentos do Mercado

Health Insurers Climb as Berkshire Hathaway Takes UnitedHealth Stake

15 de ago. de 2025, 22:22 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

15 de ago. de 2025, 22:22 UTC

Conversa de Mercado

Target Is Falling Behind Its Peers -- Market Talk

15 de ago. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

15 de ago. de 2025, 20:33 UTC

Conversa de Mercado

U.S. Treasury Yields Close the Week Little Changed -- Market Talk

15 de ago. de 2025, 20:25 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

This Meatpacker Stock Is a Quality Buy at a Discount Price -- Barrons.com

15 de ago. de 2025, 20:24 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Nucor Stock Gets a Boost From Buffett. Berkshire's Last Steel Buy Didn't Go So Well. -- Barrons.com

15 de ago. de 2025, 20:18 UTC

Ganhos

Deere's Earnings Brought a Surprise. It Wasn't the Usual Kind. -- Barrons.com

15 de ago. de 2025, 19:14 UTC

Conversa de Mercado

U.S. Natural Gas Settles Higher, But Down on Week -- Market Talk

15 de ago. de 2025, 19:12 UTC

Conversa de Mercado

Oil Futures Settle Lower Ahead of U.S.-Russia Summit -- Market Talk

15 de ago. de 2025, 18:32 UTC

Conversa de Mercado

Coffee Futures Surge on New Brazilian Frost -- Market Talk

15 de ago. de 2025, 17:33 UTC

Conversa de Mercado

U.S. Oil Rig Count Increases By 1 to 412 -- Market Talk

15 de ago. de 2025, 17:23 UTC

Conversa de Mercado
Ganhos

Deere's Earnings Appear to Be Troughing -- Market Talk

15 de ago. de 2025, 16:27 UTC

Ganhos

Tariffs Have Rocked e.l.f. Beauty Shares. Why the Fundamentals Still Look Alluring. -- Barrons.com

15 de ago. de 2025, 16:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

15 de ago. de 2025, 16:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

15 de ago. de 2025, 16:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

15 de ago. de 2025, 16:05 UTC

Aquisições, Fusões, Aquisições de Empresas

Intel's Move Toward Nationalization Won't Work -- at Least for the Long Haul -- Heard on the Street -- WSJ

15 de ago. de 2025, 15:52 UTC

Aquisições, Fusões, Aquisições de Empresas

What Applied Materials' Poor Outlook Means for Chip Stocks -- Barrons.com

15 de ago. de 2025, 15:36 UTC

Conversa de Mercado

Base Metal Prices Mixed; Copper Gains as Focus Shifts to Fundamentals -- Market Talk

15 de ago. de 2025, 15:29 UTC

Ganhos

Deere's Earnings Brought a Surprise. It Wasn't the Usual Kind. -- Barrons.com

15 de ago. de 2025, 15:29 UTC

Aquisições, Fusões, Aquisições de Empresas

Nucor Stock Gets a Boost From Buffett. Berkshire's Last Steel Buy Didn't Go So Well. -- Barrons.com

15 de ago. de 2025, 15:28 UTC

Ganhos

JD.com Stock Rises After Earnings Beat. Why Investors Are Relieved. -- Barrons.com

15 de ago. de 2025, 15:24 UTC

Conversa de Mercado

Gold Futures Tick Higher But Remain Broadly Rangebound -- Market Talk

15 de ago. de 2025, 15:08 UTC

Conversa de Mercado

Applied Materials Is Losing Share in Chips Business -- Market Talk

15 de ago. de 2025, 14:38 UTC

Aquisições, Fusões, Aquisições de Empresas

African Rainbow Minerals to Own 19.9% of Surge Copper Shares

15 de ago. de 2025, 14:37 UTC

Aquisições, Fusões, Aquisições de Empresas

African Rainbow Minerals to Buy 25.8 Million Surge Copper Shares for C$4.51M

15 de ago. de 2025, 14:37 UTC

Aquisições, Fusões, Aquisições de Empresas

African Rainbow Minerals to Buy 25.8 Million Surge Copper Shares at C$0.175 Each

15 de ago. de 2025, 14:36 UTC

Aquisições, Fusões, Aquisições de Empresas

African Rainbow Minerals to Acquire Shares of Surge Copper Corp.

15 de ago. de 2025, 14:33 UTC

Aquisições, Fusões, Aquisições de Empresas

A Trump Intel Stake Could Make National Security the New 'Too Big to Fail' -- Barrons.com

Comparação entre Pares

Variação de preço

Alkermes PLC Previsão

Preço-alvo

By TipRanks

33.05% parte superior

Previsão para 12 meses

Média 38.65 USD  33.05%

Máximo 54 USD

Mínimo 26.13 USD

Com base em 14 analistas de Wall Street que oferecem metas de preço de 12 meses para Alkermes PLC - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

14 ratings

9

Comprar

5

Manter

0

Vender

Pontuação Técnica

By Trading Central

27.95 / 30.91Suporte e Resistência

Curto Prazo

Weak Bullish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Strong Bullish Evidence

Sentimento

By Acuity

157 / 374 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Alkermes PLC

Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of marketed drug products and a clinical pipeline of products that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis (MS). The Company's products include ARISTADA, VIVITROL, INVEGA SUSTENNA, XEPLION, INVEGA TRINZA, TREVICTA, RISPERDAL CONSTA, AMPYRA, FAMPYRA, BYDUREON, Aripiprazole lauroxil, ALKS 5461, ALKS 3831, ALKS 8700, ALKS 6428, ALKS 4230 and ALKS 7119. The Company's product platforms include injectable extended-release microsphere technology, LinkeRx technology, NanoCrystal technology and oral controlled release (OCR) technology. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia.